Andrew J Griffith Selected Research

Hearing Loss (Hearing Impairment)

11/2021	Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss.
12/2017	NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy.
1/2017	Hearing loss associated with enlarged vestibular aqueduct and zero or one mutant allele of SLC26A4.
5/2013	SLC26A4 mutation testing for hearing loss associated with enlargement of the vestibular aqueduct.
12/2011	Mechanotransduction in mouse inner ear hair cells requires transmembrane channel-like genes.
11/2011	Mouse model of enlarged vestibular aqueducts defines temporal requirement of Slc26a4 expression for hearing acquisition.
6/2011	Influence of dietary iodine deficiency on the thyroid gland in Slc26a4-null mutant mice.
3/2009	Amino acid 572 in TMC1: hot spot or critical functional residue for dominant mutations causing hearing impairment.
7/2007	Disruption of fibroblast growth factor receptor 3 signaling results in defects in cellular differentiation, neuronal patterning, and hearing impairment.
4/2005	Modification of human hearing loss by plasma-membrane calcium pump PMCA2.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew J Griffith Research Topics

Disease

15	Hearing Loss (Hearing Impairment) 11/2021 - 09/2002
12	Deafness (Deaf Mutism) 01/2014 - 05/2003
6	Goiter 04/2022 - 07/2009
6	Sensorineural Hearing Loss 01/2016 - 01/2003
4	Pendred syndrome 04/2022 - 01/2011
3	type 1 Stickler syndrome 04/2004 - 01/2003
2	Usher Syndromes (Usher Syndrome) 11/2021 - 11/2011
2	Cryopyrin-Associated Periodic Syndromes 01/2020 - 12/2017
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 11/2011 - 12/2003
2	type 1F Usher syndrome 06/2006 - 12/2003
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022
1	Condylomata Acuminata (Genital Wart) 10/2022
1	Nonsyndromic Deafness 12/2017
1	Inflammation (Inflammations) 12/2017
1	Autosomal Recessive 4 Deafness 01/2017
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 09/2013
1	Melanoma (Melanoma, Malignant) 09/2013
1	Neoplasms (Cancer) 09/2013
1	Autosomal Recessive 12 Deafness 11/2011
1	Deafness, Congenital, with Inner Ear Agenesis, Microtia, and Microdontia 02/2011
1	Congenital Microtia 02/2011
1	Autosomal Recessive 28 Deafness 05/2010
1	Autosomal Dominant 36 Deafness 03/2009
1	Pallister-Hall Syndrome 07/2008
1	Keratitis-Ichthyosis-Deafness Syndrome 08/2006
1	Autosomal Recessive 23 Deafness 06/2006
1	Blindness (Hysterical Blindness) 06/2006
1	Autosomal Recessive 31 Deafness 11/2003
1	Autosomal Recessive 37 Deafness 05/2003
1	autosomal dominant nonsyndromic sensorineural 22 Deafness 05/2003
1	Marshall syndrome 01/2003
1	Autosomal Dominant 28 Deafness 11/2002

Drug/Important Bio-Agent (IBA)

3	IodineIBA 04/2022 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 05/2010 - 11/2003
2	InflammasomesIBA 01/2020 - 12/2017
2	Myosins (Myosin)IBA 01/2016 - 11/2006
2	IodidesIBA 05/2013 - 01/2011
2	Cadherins (E-Cadherin)IBA 11/2011 - 04/2005
2	perchlorateIBA 01/2011 - 07/2009
2	Transcription Factors (Transcription Factor)IBA 07/2008 - 11/2002
2	Connexin 26IBA 08/2006 - 12/2003
2	myosin VIIBA 04/2005 - 05/2003
2	Fibrillar CollagensIBA 04/2004 - 01/2003
2	Nonsense Codon (Nonsense Mutation)IBA 12/2003 - 05/2003
1	VaccinesIBA 10/2022
1	Adenosine Monophosphate (AMP)IBA 11/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 09/2013
1	Ion Channels (Ion Channel)IBA 12/2011
1	Doxycycline (Periostat)FDA LinkGeneric 11/2011
1	Fibroblast Growth Factor 3IBA 02/2011
1	Codon (Codons)IBA 03/2009
1	NucleotidesIBA 03/2009
1	Amino Acids FDA Link 03/2009
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 07/2007
1	AntigensIBA 06/2006
1	CalciumIBA 04/2005
1	Messenger RNA (mRNA)IBA 04/2004
1	CollagenIBA 04/2004
1	Collagen Type XIIBA 04/2004
1	Collagen Type II (Type II Collagen)IBA 01/2003
1	Peptides (Polypeptides)IBA 01/2003
1	Thyroid HormonesIBA 09/2002

Therapy/Procedure

3	Therapeutics 11/2021 - 11/2011
2	Cochlear Implantation 01/2017 - 02/2011
1	Cochlear Implants (Cochlear Implant) 01/2017